Abstract:Conjugated bile acids (BA), as taurocholic acid (TCA) levels, are significantly elevated in several liver pathologies. The liver is the largest lymph producing organ and has a high density of lymphatic vessels but role of hepatic lymphatics is poorly understood. BAs accumulate in metastatic lymph nodes (LN), and the lymphatics are exposed to high levels of bile in liver disease. However, whether BAs play any role in enhancing pathological lymphangiogenesis that exacerbates liver inflammation remains completely unknown. BAs activate oxidative stress pathways in liver cells and promote injury. However, these mechanisms have not been studied in the context of lymphangiogenesis. We hypothesized that the BAs activate oxidative stress response pathways such as reactive oxygen species (ROS) and p90 ribosomal S6 kinase (p90RSK) pathways and promote lymphangiogenesis. BA levels were evaluated in serum and lymph nodes (LN) of wild type (WT, FVB/NJ) and Mdr2−/− mice (mouse model of primary sclerosing cholangitis, PSC). Lymphangiogenesis was assessed in the liver and LN from these animals. Human lymphatic endothelial cells (HLECs) were treated with TCDCA (100 µM), and TCA (100 µM) for 24hrs in the presence or absence of the specific BA receptor, Takeda G‐protein receptor 5 (TGR5) antagonist (SBI‐115), and changes in lymphangiogenic genes was assessed by qPCR. Effects on LEC proliferation, invasion, migration, and tube formation were also determined. Changes in LEC cellular bioenergetics was determined by Seahorse assay. BA levels were elevated in the LN and serum of Mdr2−/− mice compared to WT. Immunohistochemical staining of liver tissue sections with cholangiocyte marker (CK19) and lymphatic marker (LYVE1) showed increased lymphangiogenesis in the MDR2−/− mice compared to WT. BAs enhanced the expression of BA receptors, farnesoid X receptor (FXR), and TGR5 on HLECs and also increased HLEC tube formation, migration, and growth of lymphatic capillaries in a 3‐D collagen matrix that was inhibited by SBI‐115, ROS inhibitor (NAC), and p90RSK inhibitor (BI‐D1870). A significant increase in maximal glycolytic capacity and ATP production was observed in the HLECs in response to BA treatment. BAs enhanced mitochondrial ROS and phosphorylated the redox‐sensitive kinase p90RSK (S380), an essential regulator of endothelial cell dysfunction in a ROS‐dependent manner. BAs also induced Prospero homeobox 1 (Prox1) SUMOylation via p90RSK activation and enhanced VEGFR3 expression, which was inhibited by BI‐D1870 and NAC. Overall, our data suggest that BA‐induced p90RSK activation plays a crucial role in the induction Prox1‐VEGFR3 axis as the precursor of lymphangiogenesis and activates a feedback loop between cellular ROS and oxidative stress activation pathways that could further promote liver injury and inflammation.

Bile Acids Improve Psoriasiform Dermatitis through Inhibition of IL-17A Expression and CCL20-CCR6–Mediated Trafficking of T Cells

Betulinic Acid Suppresses Th17 Response and Ameliorates Psoriasis-Like Murine Skin Inflammation.

Short‐chain Fatty Acids Regulate B Cells Differentiation Via the FFA2 Receptor to Alleviate Rheumatoid Arthritis

Synthesis and identification of lithocholic acid 3-sulfate as RORγt ligand to inhibit Th17 cell differentiation

Conjugated Bile Acids activate Reactive Oxygen Species‐p90RSK‐Vascular Endothelial Growth Factor Receptor 3 signaling axis to promote lymphangiogenesis

Bile acids attenuate hepatic inflammation during ischemia/reperfusion injury

Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures

Bile acid metabolites control TH17 and Treg cell differentiation

Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model

Gallic Acid Attenuates Murine Ulcerative Colitis by Promoting Group 3 Innate Lymphocytes, Affecting Gut Microbiota, and Bile Acid Metabolism

Bile Acid Derivatives Effectively Prevented High-Fat Diet-Induced Colonic Barrier Dysfunction

Bile Acids Supplementation Improves Colonic Mucosal Barrier Via Alteration of Bile Acids Metabolism and Gut Microbiota Composition in Goats with Subacute Ruminal Acidosis (SARA)

Lithocholic Acid Promotes Rosacea-Like Skin Inflammation Via G Protein-Coupled Bile Acid Receptor 1

Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion

Biochanin A Attenuates Psoriasiform Inflammation by Regulating Nrf2/HO-1 Pathway Activation and Attenuating Inflammatory Signalling

Abietic acid ameliorates psoriasis-like inflammation and modulates gut microbiota in mice

Single-cell transcriptomic landscape of immunometabolism reveals intervention candidates of ascorbate and aldarate metabolism, fatty-acid degradation and PUFA metabolism of T-cell subsets in healthy controls, psoriasis and psoriatic arthritis

Combined baicalin-zinc hyaluronate treatment of psoriasis in mice

Lipoxin A4 and Its Analog Suppress Inflammation by Modulating HMGB1 Translocation and Expression in Psoriasis

Betulinic acid attenuates cyclophosphamide-induced intestinal mucosa injury by inhibiting the NF-κB/MAPK signalling pathways and activating the Nrf2 signalling pathway

Gallic Acid Alleviates Psoriasis Keratinization and Inflammation by Regulating BRD4 Expression